BSH 2024 Registration | British Society for Haematology ASM
Registration for BSH 2024 is now open! Our ASM takes place from 28-30 April 2024 in The ACC, Liverpool. Don’t miss out on our Early Bird fees!
Registration for BSH 2024 is now open! Our ASM takes place from 28-30 April 2024 in The ACC, Liverpool. Don’t miss out on our Early Bird fees!
The FDA has granted accelerated approval to lisocabtagene maraleucel for the treatment of select adult patients with relapsed or refractory follicular lymphoma.
This noninferiority randomized trial compares the effects of a wireless system designed to provide daily feedback on progress in lifestyle change and weight loss vs…
An international genomics study has revealed distinct mutational signatures in kidney cancer that vary across different regions, illuminating the reasons behind global disparities in incidence…
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest…
This clinical insights article is derived from recommendations in Palliative Care for Patients with Cancer: ASCO Guideline. This document is based on an ASCO Guideline…
Findings from the DUO-E study support potential new durvalumab-based treatment options for patients with advanced or recurrent endometrial cancer.
Supportive care is often started late in an illness, but that may not be the best way
Is appendectomy associated with a reduced risk of a colorectal cancer subtype positive for the tumor-promoting Fusobacterium nucleatum bacteria? A recent study investigated.
Loss of induction of immunogenic cell death in response to T-DM1 leads to resistance that can be overcome by targeting TACC3, providing an attractive strategy…
Major Finding: Atypical memory (AtM) B cells reside within the tumor microenvironment and suppress antitumor immunity. Concept: A single-cell, B-cell atlas reveals a noncanonical pathway…